Welcome to our dedicated page for Strive SEC filings (Ticker: ASST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Strive, Inc. (Nasdaq: ASST) SEC filings page on Stock Titan provides direct access to the company’s official disclosures as filed with the U.S. Securities and Exchange Commission. Strive uses these filings to report on its Bitcoin treasury activities, capital structure decisions, preferred equity terms, and material corporate events, giving investors a primary source of regulatory information about ASST.
As an asset management Bitcoin treasury company, Strive’s filings often focus on digital asset holdings and financing. Form 8-K current reports describe large Bitcoin purchases funded through PIPE proceeds, warrant exercises, and the issuance of its Variable Rate Series A Perpetual Preferred Stock (SATA). These filings disclose aggregate Bitcoin holdings, acquisition costs, and the company’s view of its position among corporate Bitcoin holders.
Strive’s SEC documents also explain the detailed terms of the SATA Stock. Through 8-Ks and related exhibits, the company outlines the variable dividend structure, liquidation preference, seniority relative to common stock, compounded dividends on unpaid amounts, redemption features, and investor protections that apply if certain events occur. Additional filings report monthly dividend declarations on SATA and discuss the expected return-of-capital tax treatment of these distributions, including the company’s statement that it does not have accumulated earnings and profits.
Investors can also use Strive’s filings to review quarterly and transactional disclosures. Form 8-Ks reference quarterly financial results, the consummation of a reverse acquisition of Asset Entities Inc., and the registration of large blocks of Class A common stock for resale. Other filings describe amendments to Strive’s articles of incorporation and bylaws, changes in board composition, and the registration statements related to its proposed all-stock merger with Semler Scientific, Inc.
On Stock Titan, these filings are supplemented with AI-powered summaries that highlight key points from lengthy documents such as registration statements, 8-Ks, and prospectus supplements. Users can quickly see what each filing covers—whether it is a Bitcoin purchase disclosure, a SATA dividend update, or a merger-related communication—while retaining the ability to read the full text for deeper analysis. This makes the ASST filings page a practical starting point for understanding Strive’s regulatory history, capital markets activity, and Bitcoin-focused strategy.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, and a combined Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek their approval.
Investors are directed to review the Registration Statement and related materials when available on the SEC’s website and each company’s investor relations pages. The notice includes standard forward‑looking statement cautions and clarifies this is not an offer or solicitation to buy or sell securities.
Strive, Inc. reposted a communication on X in connection with its proposed business combination with Semler Scientific, Inc. (SMLR). The notice includes a forward‑looking statements caution and explains that Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The materials will be available free of charge on the SEC’s website and the companies’ investor sites. The communication states it is not an offer or solicitation, and identifies that Strive, Semler Scientific, and certain directors, officers, and employees may be deemed participants in the proxy solicitation for the proposed transaction.
Strive, Inc. filed a Form 425 communication regarding its proposed business combination with Semler Scientific (SMLR). Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction; the S-4 will include an information statement of Strive, a proxy statement of Semler, and a prospectus of Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek their approval. The materials will be available free on the SEC’s website and the companies’ investor sites. The communication includes forward-looking statement cautions and states it is not an offer or solicitation. Directors, officers, and employees of both companies may be participants in the proxy solicitation, with their interests to be described in the forthcoming proxy/prospectus.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific, Inc. (SMLR). The notice emphasizes forward-looking statement cautions and references Strive’s Form S-4, which registers Class A common stock to be issued in connection with the transaction. A combined Information Statement/Proxy Statement/Prospectus will be provided to Semler Scientific stockholders to seek their approval.
Investors are directed to read the Registration Statement and related materials when available, accessible free of charge on the SEC’s website and each company’s investor relations pages. The communication also notes that directors and officers of both companies may be deemed participants in the proxy solicitation, with their interests to be described in the forthcoming joint materials. It reiterates a standard no offer or solicitation disclaimer, stating that any sale of securities will occur only by means of a prospectus meeting Securities Act requirements.
Strive, Inc. reposted a communication on X regarding its proposed business combination with Semler Scientific. The message emphasizes that any forward-looking statements involve risks and uncertainties.
Strive has filed a Form S‑4 to register Class A common stock to be issued in the transaction, and an Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek approval. Investors are urged to read the Registration Statement and related materials when available on the SEC website. This communication does not constitute an offer to sell securities.
Strive, Inc. and Semler Scientific announced a proposed business combination. Strive has filed a Form S-4 to register the Class A common stock it would issue in the transaction. The combined information statement, proxy statement, and prospectus will be sent to Semler Scientific stockholders to seek their approval.
The communication includes a standard caution that any forward-looking statements involve risks and uncertainties, and references each company’s SEC filings for additional risk factors. It also notes that directors, officers, and employees of both companies may be deemed participants in the proxy solicitation.
This is not an offer or solicitation to buy or sell securities. Investors can access the Registration Statement and related materials free of charge at the SEC’s website and the companies’ investor relations pages.
Strive, Inc. filed a communication under Rule 425 regarding its proposed business combination with Semler Scientific (SMLR). Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication includes forward-looking statement cautions and states it is not an offer or solicitation to buy or sell securities.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific, Inc. (SMLR). The notice reiterates cautionary forward‑looking statements language and directs investors to SEC filings for details.
Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, which will include a combined Information Statement/Proxy Statement/Prospectus. A definitive version will be sent to Semler stockholders to seek approval of the transaction.
The communication emphasizes that it is not an offer or solicitation and that sales can occur only via a prospectus meeting Section 10 of the Securities Act or an applicable exemption. Investors are urged to read the S‑4 and related materials when available on the SEC’s website and the companies’ investor sites.
Strive, Inc. filed a communication under Rule 425 regarding its proposed business combination with Semler Scientific (SMLR). The notice, reposted by a Strive director on X.com, includes a forward‑looking statements caution and directs investors to upcoming proxy materials.
Strive has filed a Form S‑4 to register Class A common stock to be issued in the transaction. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. Documents will be available free of charge on the SEC’s website and each company’s investor site. The communication states it is not an offer or solicitation to buy or sell securities.
Strive, Inc. announced a proposed business combination with Semler Scientific via a Form 425 communication referencing a post on X.com dated November 10, 2025. Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction, and Semler Scientific stockholders will receive an information statement/proxy statement/prospectus to consider and vote on the deal. The communication includes extensive forward-looking statement cautions and directs investors to SEC filings for details. It also states this is not an offer or solicitation to sell securities.